Literature DB >> 32495906

Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.

D Han1, K Wang, T Zhang, G-C Gao, H Xu.   

Abstract

OBJECTIVE: To study the effectiveness of natural killer cell-derived exosome (NK-Exos)-entrapped paclitaxel (PTX-NK-Exos) in enhancing its anti-tumor effect.
MATERIALS AND METHODS: The NK-Exos were isolated through ultra-high-speed centrifugation, and the PTX-NK-Exos system was constructed via electroporation. The morphology, particle size, Zeta potential and entrapment rate of PTX-NK-Exos were evaluated using transmission electron microscope (TEM), dynamic light scattering (DLS), Western blotting and high-performance liquid chromatography (HPLC), respectively. The uptake of Exos in human breast cancer MCF-7 cells was observed under a laser confocal microscope. Moreover, the effect of PTX-NK-Exos on MCF-7 cell viability was determined through methyl thiazolyl tetrazolium (MTT) assay, flow cytometry and 4',6-diamidino-2-phenylindole (DAPI) staining. The effects of PTX-NK-Exos on messenger ribonucleic acid (mRNA) and protein expressions of B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax) and Caspase-3 in MCF-7 cells were detected using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting, respectively.
RESULTS: The NK-Exos were successfully isolated via ultra-high-speed centrifugation, and they had uniform particle size and high expression of markers for Exos. MCF-7 cells could take up Exos. The PTX-NK-Exos drug delivery system was successfully prepared using electroporation. In PTX group and NK-Exos group, the proliferation of MCF-7 cells declined, the nuclear apoptosis was evident and the apoptosis rate of MCF-7 cells rose compared with those in Control group. In PTX group and PTX-NK-Exos group, the migration of MCF-7 cells declined compared with that in Control group. According to the results of qRT-PCR and Western blotting, PTX-NK-Exos exerted an anti-tumor effect through inducing the up-regulation of Bax and Caspase-3 in the apoptotic signaling pathway in tumor cells.
CONCLUSIONS: Exos isolated through ultra-high-speed centrifugation can be used to prepare the PTX-NK-Exos drug delivery system through electroporation. Drug-loaded Exos can effectively inhibit proliferation and induce apoptosis of tumor cells, thereby exerting an anti-tumor effect.

Entities:  

Year:  2020        PMID: 32495906     DOI: 10.26355/eurrev_202005_21362

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

Review 1.  Exosomes as Carriers for Drug Delivery in Cancer Therapy.

Authors:  Weiping Zeng; Zhengbo Wen; Honglin Chen; Yuyou Duan
Journal:  Pharm Res       Date:  2022-03-29       Impact factor: 4.200

Review 2.  Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment.

Authors:  Ying Li; Wenjing Zhao; Yanli Wang; Haiyan Wang; Shanglong Liu
Journal:  J Nanobiotechnology       Date:  2022-05-02       Impact factor: 9.429

3.  Hypoxia enhances the production and antitumor effect of exosomes derived from natural killer cells.

Authors:  Yanan Jiang; Haiming Jiang; Kun Wang; Chunling Liu; Xuejing Man; Qiang Fu
Journal:  Ann Transl Med       Date:  2021-03

Review 4.  The Role of Exosomes in the Female Reproductive System and Breast Cancers.

Authors:  Yuqi Bai; Jie Guo; Zhongshan Liu; Yunfeng Li; Shunzi Jin; Tiejun Wang
Journal:  Onco Targets Ther       Date:  2020-12-08       Impact factor: 4.147

Review 5.  Engineered NK Cells Against Cancer and Their Potential Applications Beyond.

Authors:  Maria Karvouni; Marcos Vidal-Manrique; Andreas Lundqvist; Evren Alici
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

Review 6.  Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer.

Authors:  Roger Carles-Fontana; Nigel Heaton; Elena Palma; Shirin E Khorsandi
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

Review 7.  Exosomes: Insights and therapeutic applications in cancer.

Authors:  Anita Raj Panigrahi; Lankalapalli Srinivas; Jagadeesh Panda
Journal:  Transl Oncol       Date:  2022-05-09       Impact factor: 4.803

Review 8.  Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.

Authors:  Feifeng Wu; Min Xie; Marady Hun; Zhou She; Cuifang Li; Senlin Luo; Xiaoyu Chen; Wuqing Wan; Chuan Wen; Jidong Tian
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 9.  Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy.

Authors:  Zixuan Sun; Jiaxin Zhang; Jiali Li; Mi Li; Jing Ge; Peipei Wu; Benshuai You; Hui Qian
Journal:  Stem Cells Int       Date:  2021-07-10       Impact factor: 5.443

Review 10.  Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.

Authors:  Pengxiang Yang; Yong Peng; Yuan Feng; Zhuoying Xu; Panfeng Feng; Jie Cao; Ying Chen; Xiang Chen; Xingjian Cao; Yumin Yang; Jing Jie
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.